PannTheraPi Gets French Approval to Start Phase 2a...
Category : Clinical Trial Update 10 September 2026French clinical-stage biopharmaceutical company PannTheraPi has received approval from the French Na...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Seismic Pharmaceuticals Begins Phase 3 Trial of Is...
Category : Clinical Trial Update 10 September 2026Seismic Pharmaceuticals has enrolled the first patient in its global Phase 3 clinical trial evaluati...
Bayer Starts Phase 2 Trial of BAY 3670549 for Atri...
Category : Clinical Trial Update 10 September 2026Bayer has started a global Phase 2 clinical trial to evaluate BAY 3670549, an investigational treatm...
Alebund Pharmaceuticals Receives FDA IND Clearance...
Category : Clinical Trial Update 9 September 2026AP308 Moves Into Clinical Development Alebund Pharmaceuticals has received clearance from the U.S...
Novartis HARBOR Study of Del-desiran Misses Primar...
Category : Clinical Trial Update 9 September 2026Phase III Study Does Not Show Statistically Significant Improvement on Primary Endpoint Novartis...
Latest Newsletter Post
-
Bayer Starts Phase 2 Trial of BAY 3..
10 September 2026
-
Seismic Pharmaceuticals Begins Phas..
10 September 2026
-
PannTheraPi Gets French Approval to..
10 September 2026
-
Rezubio Completes First Cohort Dosi..
9 September 2026
-
Novartis HARBOR Study of Del-desira..
9 September 2026
